Novartis AG ADR (NVS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $303.12B
Last updated: Nov 17, 2026 at 11:06 AM ET
Novartis AG ADR (NVS) Competitors
The companies most similar to Novartis AG ADR are Novo Nordisk A/S (NVO), AstraZeneca (AZN) and Merck & Company (MRK). Novartis AG ADR trades at 18.7x earnings, against a median of 22.5x for the 9 of these companies with a P/E. By market cap, Novartis AG ADR ranks 5th of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T.
Peer Comparison
NVS's ROIC of 13.5% is below the peer median of 13.9%, and its revenue growth of 4.7% is below the median of 6.8%. Its dividend yield is above the peer median of 2.35%.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Novartis AG ADR (NVS) | $303.12B | 18.7x | 5.4x | 17.5% | 13.5% | 4.7% | 2.98% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| AstraZeneca PLC (AZN) | $286.07B | 22.5x | 4.6x | 17.7% | 14.9% | 6.7% | 1.16% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| AbbVie Inc (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| Johnson & Johnson (JNJ) | $687.89B | 26.6x | 6.9x | 16.2% | 12.8% | 5.9% | 1.90% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| Eli Lilly and Company (LLY) | $1.29T | 44.9x | 14.8x | 31.9% | 30.7% | 38.6% | 0.48% |
| Peer median | $230.18B | 22.5x | 5.0x | 15.9% | 13.9% | 6.8% | 2.35% |
Similar Companies
These are the 12 companies most similar to Novartis AG ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.
| Company | About | Peers |
|---|---|---|
| Novo Nordisk A/S (NVO) | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| AstraZeneca PLC (AZN) | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory... | AZN competitors |
| Merck & Company Inc (MRK) | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| Amgen Inc (AMGN) | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| Sanofi ADR (SNY) | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| AbbVie Inc (ABBV) | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. | ABBV competitors |
| Pfizer Inc (PFE) | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| Bristol-Myers Squibb Company (BMY) | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Gilead Sciences Inc (GILD) | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| Johnson & Johnson (JNJ) | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. | JNJ competitors |
| GSK plc (GSK) | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| Eli Lilly and Company (LLY) | Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. | LLY competitors |
Frequently Asked Questions About NVS
Who are Novartis AG ADR's main competitors?
The companies most similar to Novartis AG ADR include Novo Nordisk A/S (NVO), AstraZeneca (AZN), Merck & Company (MRK), Amgen (AMGN) and Sanofi ADR (SNY), listed from the closest match.
Who is Novartis AG ADR's biggest competitor?
Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; Novo Nordisk A/S (NVO) is the closest match by business profile, size, sector and industry.
How does NVS stock compare with its competitors?
NVS' P/E is 18.7x against a peer median of 22.5x; its P/S is 5.4x against a peer median of 5.0x; its net margin is 17.5% against a peer median of 15.9%.
Which of Novartis AG ADR's competitors pays a higher dividend?
Novartis AG ADR has a forward dividend yield of 2.98%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY) and GSK (GSK) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.
Is Novartis AG ADR bigger than its competitors?
No. Novartis AG ADR is 5th by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.
NVS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts